Anticoagulation poses unique challenges for women of reproductive age. Clinicians
prescribing anticoagulants must counsel patients on issues ranging from menstruation and …

Women who are receiving an oral anticoagulant appear to be at higher risk of developing
bleeding-related adverse events than men. Physiological bleeding related to the ovulatory …

Abnormal or excessive menstrual bleeding affects one‐third of reproductive‐aged women.
This number increases to 70% among women on direct oral anticoagulants (DOACs). While …

Guidelines for Use of Anticoagulation in Pregnancy - Clinics in Laboratory Medicine Skip to
Main Content Advertisement Clinics in Laboratory Medicine Log in Register Log in Subscribe …

Heightened publicity about hormonal contraception and thrombosis risk and the publication
of new guidelines by the World Health Organization in 2009 and the Centers for Disease …

In premenopausal women treatment with direct oral anticoagulants (DOACs) can be
associated with an increased risk of heavy menstrual bleeding (HMB) compared with vitamin …

Estrogen exposure, in the setting of pregnancy, the postpartum state, combined hormonal
contraceptives (CHCs), or hormone therapy use, has been clearly associated with increased …

Managing contraception for women at high risk for thrombosis poses unique challenges.
Combined estrogen and progestin contraceptives increase the risk of both venous and …

BACKGROUND: Oral anticoagulation is associated with increased bleeding complications.
The aim of this study was to assess the changes in menstrual loss and pattern in women …

Anticoagulant-associated heavy menstrual bleeding (HMB) is an underrecognized but not
uncommon problem in clinical practice. Premenopausal women should be advised of the …